The Cedars-Sinai accelerator, which is powered by Techstars, announced its third cohort of startups this fall. Now, the 10 selected companies have unveiled deals and partnerships with various players in the healthcare space.
Whittled down from roughly 600 applicants, the goals of the 10 companies in the third cohort include improving the patient experience, offering more personalized care plans for cancer treatment, triaging patients faster and making blood sample collection less painful.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.